Evidence map›Paper›PMID 40322838›Full record

ArticleThe FEBS journal2025

Electrostatic potential as a reactivity scoring function in computer-assisted enzyme engineering.

Aitor Vega, Antoni Planas, Xevi Biarnés

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aitor VegaLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5851-3245
Antoni PlanasLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, Barcelona, Spain.ORCID https://orcid.org/0000-0001-7073-3320
Xevi BiarnésLaboratory of Biochemistry, Institut Químic de Sarrià, University Ramon Llull, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4121-9474

Funding

Ministry of Science and Innovation, Spain GLYCODESIGN (PID2019-104350RB-I00)Ministry of Science and Innovation, Spain GLYCOENGIN (PID2022-138252OB-I00)Ramon Llull University/Obra Social la Caixa BINDSCAN 2.0'2020
6 · The paper itself

Abstract

The high catalytic efficiency of enzymes is attained, in part, by their capacity to stabilize electrostatically the transition state of the chemical reaction. High-throughput protocols for measuring this electrostatic contribution in computer-assisted enzyme design are limited. We present here an easy-to-compute metric that captures the electrostatic complementarity of the enzyme to the charge distribution of the substrate at the transition state. We demonstrate such a complementarity for a representative dataset of glycoside hydrolases, a large family of enzymes responsible for the hydrolytic cleavage of glycosidic bonds in oligosaccharides, polysaccharides, and glycoconjugates. We have implemented this metric in BindScan, a computer-based mutational analysis protocol to assist protein engineering. We demonstrate the predictive power of BindScan with this metric for two mechanistically distinct glycoside hydrolases: Spodoptera frugiperda β-glucosidase (Sfβgly, operates via protein nucleophile catalysis) and Bifidobacterium bifidum lacto-N-biosidase (BbLnbB, operates via substrate-assisted catalysis). The metric correctly predicts sequence positions sensible to the modulation of k

Indexed as

beta-GlucosidaseGlycoside HydrolasesProtein EngineeringAnimalsKineticsModels, MolecularMutationSpodopteraStatic Electricitybeta-GlucosidaseGlycoside Hydrolasesbinding affinitycomputational protein engineeringelectrostatic potentialglycoside hydrolasestransglycosylation

Identifiers

PMID40322838
PMCPMC12366256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.